Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CS50 | ISIN: BE0974386188 | Ticker-Symbol: 86C
Frankfurt
03.05.24
08:15 Uhr
3,030 Euro
-0,060
-1,94 %
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOTALYS NV Chart 1 Jahr
5-Tage-Chart
BIOTALYS NV 5-Tage-Chart
RealtimeGeldBriefZeit
3,0403,16019:02
GlobeNewswire (Europe)
467 Leser
Artikel bewerten:
(2)

Biotalys NV: Publication of transparency notification

Ghent, BELGIUM, July 05, 2023 (GLOBE NEWSWIRE) -- Press release - regulated information

Publication of transparency notification
(Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares are admitted to trading on a regulated market)

Biotalys(the "Company" or "Biotalys"), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for crop and food protection, announces today, in accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings in issuers whose shares are admitted to trading on a regulated market (the 'Belgian Transparency Act'), that it has received a transparency notification from Biovest NV and RMM SA.

Biovest NV has announced that, on 30 June 2023, it transferred 1,815,465 shares in the Company to its holding company RMM SA, representing 5.66% of the total number of voting rights.

The notification dated 30 June 2023 contains the following information:

  • Reason for the notification: acquisition or transfer of voting securities
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Stefan Mariën
    • Sniper Invest SA, Route d'Arlon 19-21 L 8009 Strassen Luxembourg
    • Frederic Mariën
    • Fontana Invest SA, Route d'Arlon 19-21 L 8009 Strassen Luxembourg
    • Robin Devos
    • Radium Invest SA, Route d'Arlon 19-21 L 8009 Strassen Luxembourg
    • RMM SA, Route d'Arlon 19-21 L 8009 Strassen Luxembourg
    • Biovest NV, Karel van de Woestijnestraat 3, 9000 Ghent
  • Date on which the threshold was crossed: 30 June 2023
  • Threshold that is crossed: 5%
  • Denominator: 32,094,711
  • Notified details:

Voting rightsPrevious notificationAfter the transaction
# of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked to the securitiesLinked to securitiesNot linked to the securities
Stefan Mariën0000.00%0.00%
Sniper Invest SA0000.00%0.00%
Frederic Mariën0000.00%0.00%
Fontana Invest SA0000.00%0.00%
Robin Devos0000.00%0.00%
Radium Invest SA0000.00%0.00%
RMM SA01,815,46505.66%0.00%
Biovest NV2,048,798000.00%0.00%
TOTAL1,815,46505.66%0.00%
  • RMM SA is the owner of 100% of shares in Biovest NV and is ultimately owned by Sniper Invest SA (ultimately owned by Stefan Mariën), Fontana Invest SA (ultimately owned by Frederic Mariën), and Radium Invest SA (ultimately owned by Robin Devos), each for one third.

The transparency notifications can be found on www.biotalys.com/investors.

For further information, please contact:

Toon Musschoot, Head of Investor Relations and Communications

T: +32 (0)9 274 54 00

E: Toon.Musschoot@biotalys.com

About Biotalys

Biotalys is an Agricultural Technology.

Attachments

  • Biotalys Publicatie Transparantiemelding_NL_050723 (https://ml.globenewswire.com/Resource/Download/04e63c6b-549f-48dd-849f-a10b842bb44b)
  • Biotalys Publication of Transparency Notification_ENG_050723 (https://ml.globenewswire.com/Resource/Download/c7981694-473e-48a2-8c9a-94787af52263)

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2023 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.